CG
MRK icon

Cynosure Group’s Merck MRK Stock Holding History

Cynosure Group’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,683
Closed -$598K – 367
2025
Q4 		$598K Sell
5,683
-76
-1% -$7.13K 0.06% 112
2025
Q3 		$483K Hold
5,759
– – 0.05% 204
2025
Q2 		$456K Buy
5,759
+1,544
+37% +$123K 0.05% 198
2025
Q1 		$378K Buy
4,215
+671
+19% +$62.6K 0.05% 176
2024
Q4 		$353K Sell
3,544
-710
-17% -$73.2K 0.05% 166
2024
Q3 		$483K Buy
4,254
+656
+18% +$77.9K 0.07% 162
2024
Q2 		$445K Buy
3,598
+377
+12% +$48.6K 0.07% 152
2024
Q1 		$425K Sell
3,221
-25,866
-89% -$3.19M 0.08% 133
2023
Q4 		$3.17M Buy
29,087
+18,645
+179% +$1.94M 0.57% 45
2023
Q3 		$1.08M Sell
10,442
-134
-1% -$14.4K 0.33% 70
2023
Q2 		$1.22M Buy
+10,576
New +$1.2M 0.37% 61

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cynosure Group's MRK Position: Q1 2026 in Review

Cynosure Group sold out of Merck (MRK) in Q1 2026, closing a stake of 5,683 shares — an estimated $598K sold.

Cynosure Group first reported a position in MRK in Q2 2023 and held it in 11 quarters. The position peaked at $3.17M in Q4 2023. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cynosure Group reported no remaining Merck position as of Q1 2026 after selling out during the quarter.
  • Cynosure Group sold 5,683 Merck shares in Q1 2026, an estimated $598K.
  • Cynosure Group first reported a position in Merck in Q2 2023 and held it in 11 quarters.
  • Cynosure Group's Merck position peaked at $3.17M in Q4 2023.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.